Table 2.
Reactivation in patients with inflammatory bowel disease undergoing immunosuppressive therapy
Ref. | HBsAg+ | HBcAb+ | HCV+ |
Loras et al[60] | 9/25 | 0/65 | 8/51 |
Morisco et al[65] | 1/6 | 1/4 | 1/10 |
Papa et al[54] | 0/1 | 0/22 | 0/4 |
HBsAg: Hepatitis B surface antigen; HBcAb: Hepatitis B core antibody; HCV: Hepatitis C virus.